🔴 Senti Biosciences is trading 16.59% down in pre-market; no fresh company-specific catalyst identified

Senti Biosciences is trading at $0.18, down 16.59% in pre-market on October 30, 2026, with no fresh company-specific catalyst identified.

• The S&P 500 was down 0.99% and Nasdaq Composite down 2.17%; broader risk-off sentiment may be contributing, but a direct link is unconfirmed.
• The board resignation and CVR record date were announced earlier.
• No pre-market volume data was provided, so trading activity cannot be assessed.